Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Herskovitz

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 25, 2018
HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral EradicationJonathan Herskovitz, Howard E Gendelman
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR TherapyJonathan Herskovitz, Mahmudul Hasan, Milankumar Patel, et al.
The AAPS Journal|January 11, 2017
Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic ExposureJonathan Herskovitz, Josiah Ryman, Theingi Thway, et al.
Molecular Neurodegeneration|June 7, 2020
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disordersJatin Machhi, Bhavesh D Kevadiya, Ijaz Khan Muhammad, et al.
Infection Control and Hospital Epidemiology|October 2, 2023
Demographic representation among speakers at the Society for Healthcare Epidemiology of America (SHEA) spring conferencesZanthia Wiley, Ibukunoluwa C Kalu, Elizabeth Lyden, et al.
Science (New York, N.Y.)|April 13, 2013
Blockade of chronic type I interferon signaling to control persistent LCMV infectionElizabeth B Wilson, Douglas H Yamada, Heidi Elsaesser, et al.
Ebiomedicine|November 14, 2021
CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 EliminationJonathan Herskovitz, Mahmudul Hasan, Milankumar Patel, et al.
Oncotarget|February 4, 2016
Amyloid precursor protein and amyloid precursor-like protein 2 in cancerPoomy Pandey, Bailee Sliker, Haley L Peters, et al.
Biomaterials|September 17, 2019
A long acting nanoformulated lamivudine ProTideNathan Smith, Aditya N Bade, Dhruvkumar Soni, et al.
Nanotheranostics|May 11, 2021
Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirsJonathan Herskovitz, Mahmudul Hasan, Jatin Machhi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 25, 2018
HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral EradicationJonathan Herskovitz, Howard E Gendelman
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR TherapyJonathan Herskovitz, Mahmudul Hasan, Milankumar Patel, et al.
The AAPS Journal|January 11, 2017
Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic ExposureJonathan Herskovitz, Josiah Ryman, Theingi Thway, et al.
Molecular Neurodegeneration|June 7, 2020
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disordersJatin Machhi, Bhavesh D Kevadiya, Ijaz Khan Muhammad, et al.
Infection Control and Hospital Epidemiology|October 2, 2023
Demographic representation among speakers at the Society for Healthcare Epidemiology of America (SHEA) spring conferencesZanthia Wiley, Ibukunoluwa C Kalu, Elizabeth Lyden, et al.
Science (New York, N.Y.)|April 13, 2013
Blockade of chronic type I interferon signaling to control persistent LCMV infectionElizabeth B Wilson, Douglas H Yamada, Heidi Elsaesser, et al.
Ebiomedicine|November 14, 2021
CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 EliminationJonathan Herskovitz, Mahmudul Hasan, Milankumar Patel, et al.
Oncotarget|February 4, 2016
Amyloid precursor protein and amyloid precursor-like protein 2 in cancerPoomy Pandey, Bailee Sliker, Haley L Peters, et al.
Biomaterials|September 17, 2019
A long acting nanoformulated lamivudine ProTideNathan Smith, Aditya N Bade, Dhruvkumar Soni, et al.
Nanotheranostics|May 11, 2021
Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirsJonathan Herskovitz, Mahmudul Hasan, Jatin Machhi, et al.
Pageof 3